Pharma Focus Asia

Cambrex Constructs New Stability Storage Facility in Belgium, Europe

Introduction:

Cambrex plans to construct new stability storage facility to the pharmaceutical, medical device and life sciences industries across Europe.

Features:

The new cGMP facility laid with 20,000 square feet will expand the capacity for environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries across Europe.

The new state-of-the-art temperature-controlled and monitored storage facility offers 35,000 temperature-controlled storage areas for all major ICH climate zones, including long-term, medium and accelerated stability tests, including 2 – 8°C, 25°C / 60 percent RH and 40°C / 75 percent RH.

This expansion enables easy accessible capacity in continental Europe and the flexibility to respond quickly and efficiently to changing customer demands and serve pharmaceutical companies across Europe.

This expansion complements first quarter scientific's existing footprint in Waterford, Ireland and aligns with Cambrex's to expand its portfolio of speciality drug development and manufacturing solutions in North America and Europe.

Specifications:

Name    Cambrex
Type    New Construction

magazine-slider-imageCytiva - Supor Prime filtersMFA + MMA 2024CPHI China || PMEC China 2024Asia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024World Orphan Drug Congress Europe 2024INALAB 2024Advanced Therapies USA 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference3rd World ADC Asia 2024LogiPharma Asia 2024